Rising prevalence of drug-resistant infections and government-led monitoring initiatives drive a steady 5.47% CAGR through 2035.Austin, United States, April 02, 2026 (GLOBE NEWSWIRE) -- As per SNS ...

Learn more about whether Relay Therapeutics, Inc. or Twist Bioscience Corporation is a better investment based on AAII's A+ ...

Global Molecular Infectious Disease Testing Market OverviewThe global Molecular Infectious Disease Testing Market encompasses ...

The CBSE Class 12 Biology exam 2026 is scheduled for March 27, Friday. Experts emphasize that conceptual understanding, ...

Symeres has entered a collaboration with Ambagon Therapeutics on molecular glue research in colorectal cancer, aiming to ...

Symeres, Ambagon Therapeutics collaborate on molecular glue research in colorectal cancer: Nijmegen, Netherlands Thursday, April 2, 2026, 12:00 Hrs [IST] Symeres, a leading CRDMO ...

Unlock the latest liquid biopsy market data. Explore growth drivers, precision oncology shifts, and the tech fueling ...

Symeres and Ambagon Therapeutics collaborate on molecular glue research in colorectal cancerNijmegen, Netherlands [31.03.2026] – Symeres, a leading CRDMO for drug discovery and development has ...

The COVID-19 pandemic led to many changes. Among them is universal familiarity with a molecular diagnostic technique that was largely unknown outside clinical use. The polymerase chain reaction — or ...

The research aims to develop insights into colorectal cancer A leading CRDMO for drug discovery and development Symeres has partnered with Ambagon Therapeutics, a pre-clinical biotechnology company, ...

A cell-free peptide ligase display platform developed in Japan has enabled rapid, high-precision screening of target-binding ...

U.S. Molecular Diagnostics Market size was valued at USD 5.0 Billion in 2025 and is projected to reach USD 8.07 Billion by 2035 due to increasing chronic diseases in the country.Austin, April 03, 2026 ...